HOUGEN ELIZABETH L bought ARTV
September 8, 2026 · Form 4 insider transaction
HOUGEN ELIZABETH L bought 13,750 shares of Artiva Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,750
Price
$0.00
Total value
N/A
InsiderHOUGEN ELIZABETH L
RoleDirector
SecurityDirector Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 8, 2026
Filing dateSeptember 8, 2026
Shares owned after13,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option will vest in full on the earlier of September 8, 2027, or the date of the Issuer's 2027 annual stockholder meeting.